Nogales Bruce 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Aug 26, 2010
Insider Transaction Report
Form 4
Nogales Bruce
Sr. VP & GM, Plasma Resources
Transactions
- Exercise/Conversion
Common Stock
2010-08-25$11.00/sh+4,834$53,174→ 47,993 total - Exercise/Conversion
Common Stock
2010-08-26$1.39/sh+21,267$29,561→ 39,760 total - Sale
Common Stock
2010-08-26$22.00/sh−37,005$813,936→ 5,921 total - Exercise/Conversion
Options (right to buy)
2010-08-25$11.00/sh−4,834$53,174→ 3,166 totalExercise: $11.00From: 2008-04-01Exp: 2017-07-09→ Common Stock (4,834 underlying) - Exercise/Conversion
Options (right to buy)
2010-08-25$1.39/sh−18,733$26,039→ 86,707 totalExercise: $1.39Exp: 2015-11-10→ Common Stock (18,733 underlying) - Exercise/Conversion
Options (right to buy)
2010-08-26$1.39/sh−21,267$29,561→ 65,440 totalExercise: $1.39Exp: 2015-11-10→ Common Stock (21,267 underlying) - Sale
Common Stock
2010-08-25$21.92/sh−29,500$646,726→ 18,493 total - Exercise/Conversion
Common Stock
2010-08-26$11.00/sh+3,166$34,826→ 42,926 total - Exercise/Conversion
Options (right to buy)
2010-08-26$11.00/sh−3,166$34,826→ 0 totalExercise: $11.00From: 2008-04-01Exp: 2017-07-09→ Common Stock (3,166 underlying) - Exercise/Conversion
Common Stock
2010-08-25$1.39/sh+18,733$26,039→ 43,159 total
Holdings
- 11,755
Options (right to buy)
Exercise: $19.00Exp: 2019-09-30→ Common Stock (11,755 underlying)
Footnotes (6)
- [F1]The transaction reported was effected purusant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 5,921 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.81 to $21.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 4 that follows.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.95 to $22.05, inclusive.
- [F5]The option is fully vested and immediately exercisable.
- [F6]Option will vest in three equal annual installments beginning April 1, 2011, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.